Since 2012, more than 70,000 adult patients have been prescribed XELJANZ to treat their moderate to severe rheumatoid arthritis.*
In 2017, XELJANZ was approved to treat adult patients with active psoriatic arthritis.
And now XELJANZ is approved to treat adult patients with moderate to severe ulcerative colitis.
Talk to your doctor about XELJANZ—a small pill. Not an injection or infusion.